Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer

PURPOSE: Percutaneous hepatic perfusion with melphalan (M-PHP) is increasingly used in patients with liver metastases from various primary tumors, yet data on colorectal liver metastases (CRLM) are limited. The aim of this study was to prospectively evaluate the efficacy and safety of M-PHP in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, T. Susanna, Dieters, Jan H. N., de Leede, Eleonora M., de Geus-Oei, Lioe-Fee, Vuijk, Jaap, Martini, Christian H., van Erkel, Arian R., Lutjeboer, Jacob, van der Meer, Rutger W., Tijl, Fred G. J., Kapiteijn, Ellen, Vahrmeijer, Alexander L., Burgmans, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758076/
https://www.ncbi.nlm.nih.gov/pubmed/35025911
http://dx.doi.org/10.1371/journal.pone.0261939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758076/
https://www.ncbi.nlm.nih.gov/pubmed/35025911
http://dx.doi.org/10.1371/journal.pone.0261939

Ejemplares similares